Fundraising Fox

Halomine

Founded 2018 · 18 employees on LinkedIn · 4 known investors

AvantGuard develops Avantamine, an antimicrobial molecule that eliminates bacteria, viruses, and fungi on surfaces and skin without generating resistance, with an initial focus on topical treatment of the drug-resistant fungal pathogen Candida auris. The technology can be formulated as an antiseptic, disinfectant, surface coating, or plastics additive for use in healthcare settings.

BiotechHealthtechNew Materials

Investors · 4

Red Bear AngelsIthaca · $100K – $1M
Blue Ledge Capitalreported
SOSVreportedNew York · $30K – $550K

Also in the syndicate · 1

LaunchNY

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Non-dilutive funding · 9 SBIR/STTR awards

Federal grants — no equity taken
AgencyPhaseYearAmount
National Institutes of Health (NIH)National Institutes of HealthPhase II2023$1M
National Institutes of Health (NIH)National Institutes of HealthPhase I2023$325K
Department of Agriculture (USDA)Phase I2022$175K
National Science FoundationPhase II2021$1M
Department of Agriculture (USDA)Phase II2020$600K
National Science FoundationPhase I2020$256K
National Institutes of Health (NIH)National Institutes of HealthPhase I2020$250.3K
National Science FoundationPhase I2020$225K
U.S. ArmyArmyPhase I2020$99.9K

Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.

In the news

AvantGuard Closes $2.85 Million Seed Funding Round - I-Corps Hub: Interior Northeastin-icorps.org · Jun 2023IndieBio’s Halomine and Inso Biosciences win New York state funding for disease outbreak prevention - SOSVindiebio.co · Nov 2022Halomine Inc. Awarded $1M Funding From National Science Foundation (NSF) to Help Product Developmentavantguardinc.com · Oct 2021Germs, Interrupted: Disinfection Innovation Goes Global - IndieBio - #1 in Early Stage Biotechindiebio.co · Jul 2021Halomine™ Receives“Red Bear Angel” Fundingavantguardinc.com · Jun 2020

Frequently asked questions

What does Halomine do?
AvantGuard develops Avantamine, an antimicrobial molecule that eliminates bacteria, viruses, and fungi on surfaces and skin without generating resistance, with an initial focus on topical treatment of the drug-resistant fungal pathogen Candida auris. The technology can be formulated as an antiseptic, disinfectant, surface coating, or plastics additive for use in healthcare settings.
Who are Halomine's investors?
Halomine's investors include Red Bear Angels, Blue Ledge Capital, SOSV.